M

Medpace Holdings
D

MEDP

337.20
USD
-4.91
(-1.44%)
Market Closed
Volume
12,298
EPS
11
Div Yield
-
P/E
30
Market Cap
10,480,715,857
OverviewSignalsIdeasNews
Related Instruments
    C
    CAH
    -2.540
    (-2.09%)
    118.790 USD
    CNC
    CNC
    -1.260
    (-2.15%)
    57.430 USD
    D
    DVA
    5.950
    (3.85%)
    160.340 USD
    E
    EVH
    -0.280
    (-2.21%)
    12.380 USD
    HCA
    HCA
    -2.41
    (-0.70%)
    342.95 USD
    MCK
    MCK
    -3.56
    (-0.58%)
    606.42 USD
    O
    OMCL
    -0.900
    (-1.93%)
    45.710 USD
    T
    THC
    -7.320
    (-4.50%)
    155.340 USD
    U
    UHS
    0.710
    (0.35%)
    201.710 USD
    More
News

Title: Medpace Holdings

Sector: Healthcare
Industry: Diagnostics & Research
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.